Cadence Pharmaceuticals Inc. (CADX) was a big mover last session, as the company saw its shares rise by 34% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up over 36% in the past one-month time frame.
This biopharmaceutical stock has seen two positive estimate revisions in the past one month and its Zacks Consensus Estimate has also moved higher over the same time frame, suggesting that more solid trading ahead. So make sure to keep an eye on this stock, going forward, to see if the current rally can turn into more strength down the road.
Cadence currently has a Zacks Rank #3 (Hold) and its Earnings ESP is positive.
However, some better performing stocks in the same industry are BioSpecifics Technologies Corp. (BSTC), Furiex Pharmaceuticals, Inc. (FURX) and Jazz Pharmaceuticals Public Limited Company (JAZZ). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment